The Outcome of Salvage Liver Transplantation and Liver Resection for Recurrent Hepatocellular Carcinoma Using the 5-5-500 Rule, Japanese Extended Liver Transplantation Criteria for Hepatocellular Carcinoma

被引:1
|
作者
Hirata, Yoshihiro [1 ,3 ]
Kotera, Yoshihito [1 ]
Kato, Takaaki [1 ]
Ariizumi, Syunichi [1 ]
Kogiso, Tomomi
Tokushige, Katsutoshi [2 ]
Honda, Goro [1 ]
Egawa, Hiroto [1 ]
机构
[1] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Hepatobiliary Pancreat Surg, Shinjuku Ku, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Gastroenterol, Shinjuku Ku, Tokyo, Japan
[3] Tokyo Womens Med Univ, 8-1, Kawada Cho,Shinjuku Ku, Tokyo 1628666, Japan
关键词
REPEAT HEPATECTOMY; TUMOR SIZE; IMPACT;
D O I
10.1016/j.transproceed.2023.04.028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Liver transplantation (LT) for hepatocellular carcinoma (HCC) is limited to Child-Pugh class C patients according to the Japanese HCC treatment algorithm. However, extended criteria of LT for HCC, known as the 5-5-500 rule, were published in 2019. Hepatocellular carcinoma reportedly has a high recurrence rate after primary treatment. We hypothesized that the outcome of recurrent HCC would be improved if the 5-5-500 rule were adopted for patients with recurrent HCC. We, therefore, analyzed the outcomes of surgical treatment (liver resection [LR] and LT) for recurrent HCC using the 5-5-500 rule in our institute.Methods. Fifty-two patients younger than 70 years of age received surgical treatment for recurrent HCC using our institute's 5-5-500 rule from 2010 to 2019. We divided these patients into the LR and LT groups in the first study. The 10-year overall survival and re-recurrence-free survival were analyzed. The second study analyzed the risk factors of re-recurrence after surgical treatment for recurrent HCC.Results. In the first study, the background characteristics of the 2 groups (LR and LT) showed no significant difference, except for age and Child-Pugh classification. There was no significant difference in the overall survival between groups (P = .35), but the re-recurrence-free survival in the LR group was significantly shorter than that in the LT group (P < .01). In the second study, the male sex and LR were risk factors of re-recurrence after surgical treatment for recurrent HCC. Child-Pugh's class did not contribute to re-recurrence. Conclusions. To improve the outcomes of recurrent HCC, LT is the better choice, regardless of the Child-Pugh class.
引用
收藏
页码:901 / 905
页数:5
相关论文
共 50 条
  • [1] Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
    Liu, Fei
    Wei, Yonggang
    Wang, Wentao
    Chen, Kefei
    Yan, Lvnan
    Wen, Tianfu
    Zhao, Jichun
    Xu, Mingqing
    Li, Bo
    PLOS ONE, 2012, 7 (11):
  • [2] Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study
    Shimamura, Tsuyoshi
    Akamatsu, Nobuhisa
    Fujiyoshi, Masato
    Kawaguchi, Atushi
    Morita, Satoshi
    Kawasaki, Seiji
    Uemoto, Shinji
    Kokudo, Norihiro
    Hasegawa, Kiyoshi
    Ohdan, Hideki
    Egawa, Hiroto
    Furukawa, Hiroyuki
    Todo, Satoru
    TRANSPLANT INTERNATIONAL, 2019, 32 (04) : 356 - 368
  • [3] Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation
    Shan, Yuhua
    Huang, Lifeng
    Xia, Qiang
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Hepatocellular Carcinoma: Resection or Liver Transplantation?
    Merdrignac, A.
    Maillot, B.
    Garnier, J.
    Jeddou, H.
    Rayar, M.
    Houssel, P.
    Boudjema, K.
    ONCOLOGIE, 2017, 19 (5-6) : 152 - 157
  • [5] Liver transplantation for hepatocellular carcinoma: the Japanese experience
    Furukawa, Hiroyuki
    Shimamura, Tsuyoshi
    Suzuki, Tomomi
    Taniguchi, Masahiko
    Nakanishi, Kazuaki
    Yamashita, Kenichiro
    Kamiyama, Toshiya
    Matsushita, Michiaki
    Todo, Satoru
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (05) : 533 - 538
  • [6] Controversies in criteria for liver transplantation in hepatocellular carcinoma
    Parikh, Neehar D.
    Yopp, Adam
    Singal, Amit G.
    CURRENT OPINION IN GASTROENTEROLOGY, 2016, 32 (03) : 182 - 188
  • [7] Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma
    Yilma, Mignote
    Mehta, Neil
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 33 (01) : 133 - 142
  • [8] Extended Criteria for Living Donor Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
    Choi, H. J.
    Kim, D. G.
    Na, G. H.
    Hong, T. H.
    You, Y. K.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (02) : 399 - 402
  • [9] Liver transplantation for hepatocellular carcinoma
    Berumen, Jennifer
    Hemming, Alan
    ABDOMINAL RADIOLOGY, 2018, 43 (01) : 185 - 192
  • [10] Options for the treatment of intrahepatic recurrent hepatocellular carcinoma: Salvage liver transplantation or rehepatectomy?
    Fang, Jiong-Ze
    Xiang, Li
    Hu, Yang-Ke
    Yang, Yong
    Zhu, Hong-Da
    Lu, Cai-De
    CLINICAL TRANSPLANTATION, 2020, 34 (05)